Evidence map›Paper›PMID 29158717›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2017

Adverse drug reactions in high-risk pregnant women: A prospective study.

Alfredo Dias de Oliveira-Filho, Antonio Emanuel Soares Vieira, Roberta Cruz da Silva, Sabrina Joany Felizardo Neves, Thiago Antonio Barros Gama, Ryane Vieira Lima, Wlisses Ramon Oliveira, Júlia Maria de Gonçalves Dias

Open access · hybridAbstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alfredo Dias de Oliveira-FilhoNúcleo de Estudos em Farmacoterapia (NEF), School of Nursing and Pharmacy (ESENFAR), Federal University of Alagoas, Brazil.
Antonio Emanuel Soares VieiraNúcleo de Estudos em Farmacoterapia (NEF), School of Nursing and Pharmacy (ESENFAR), Federal University of Alagoas, Brazil.
Roberta Cruz da SilvaDepartment of Medicine, Federal University of Sergipe, Brazil.
Sabrina Joany Felizardo NevesNúcleo de Estudos em Farmacoterapia (NEF), School of Nursing and Pharmacy (ESENFAR), Federal University of Alagoas, Brazil.
Thiago Antonio Barros GamaDepartment of Medicine, Federal University of Sergipe, Brazil.
Ryane Vieira LimaDepartment of Medicine, Federal University of Sergipe, Brazil.
Wlisses Ramon OliveiraDepartment of Medicine, Federal University of Sergipe, Brazil.
Júlia Maria de Gonçalves DiasDepartment of Medicine, Federal University of Sergipe, Brazil.
Universidade Federal de Sergipe · BRUniversidade Federal de Alagoas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBecause pregnant women are often excluded from clinical trials, there is still very limited information about the risk and safety of prescription drugs during pregnancy.

objectiveWe aimed to determine the prevalence of Adverse Drug Reactions (ADRs) in high-risk pregnant women after hospital admission. A prospective study was carried out in a teaching maternity hospital in Brazil during six months. Causality of ADRs was assessed through the Naranjo Algorithm and Korean Algorithm for ADR Causality Assessment. Severity of ADRs was assessed using Hartwig's Severity Assessment Scale.

resultsThe prevalence of ADRs among the 294 inpatients studied was 8.8%. The mean age was 27.14 (±7.5) y.o. Patient's age was related to the presence of ADRs, while the manifestation of these events was not associated with any adverse pregnancy outcome. 75.9% of the ADRs reported in the study were of mild severity and 24.1% were of moderate severity. No ADR was caused by drug-drug interaction; however, a significant increase in blood pressure was observed in all patients using concurrent methyldopa and ferrous sulfate.

conclusionOverall, ADRs were not common events among high-risk pregnant women and no adverse pregnancy outcomes following these events were observed.

Indexed as

Adverse drug reactionsDrug-drug interactionsFerrous sulfateHigh-risk pregnancyMaternal ageMethyldopaPrevalence

Identifiers

PMID29158717
PMCPMC5681315
OpenAlexW2585286825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.